Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


2 Ann Surg Oncol
4 Anticancer Res
1 Br J Cancer
1 Cancer Lett
2 Cancer Res
1 Clin Cancer Res
1 Eur J Dermatol
1 Int J Cancer
4 J Am Acad Dermatol
1 J Clin Oncol
1 J Invest Dermatol
2 Melanoma Res
1 Nat Med
3 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Surg Oncol

  1. THOMPSON JF, Scolyer RA, Lo SN
    ASO Author Reflections: Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas.
    Ann Surg Oncol. 2018 Nov 9. pii: 10.1245/s10434-018-7014.
    PubMed     Text format    

    ASO Author Reflections: Metastatic Melanoma to the Large Bowel.
    Ann Surg Oncol. 2018 Nov 7. pii: 10.1245/s10434-018-6972.
    PubMed     Text format    

    Anticancer Res

  3. ERDMANN M, Sigler D, Uslu U, Gohl J, et al
    Risk Factors for Regional and Systemic Metastases in Patients with Sentinel Lymph Node-negative Melanoma.
    Anticancer Res. 2018;38:6571-6577.
    PubMed     Text format     Abstract available

  4. SUZUKI H, Takano G, Hanai N, Nishikawa D, et al
    Primary Tumor Size Predicts Distant Metastasis of Mucosal Malignant Melanoma in Head and Neck.
    Anticancer Res. 2018;38:6485-6490.
    PubMed     Text format     Abstract available

  5. MATTILA K, Raanta P, Lahtela V, Pyrhonen S, et al
    Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha.
    Anticancer Res. 2018;38:6393-6397.
    PubMed     Text format     Abstract available

  6. PAMIDIMUKKALA NV, Leonard MK, Snyder D, McCorkle JR, et al
    Metastasis Suppressor NME1 Directly Activates Transcription of the ALDOC Gene in Melanoma Cells.
    Anticancer Res. 2018;38:6059-6068.
    PubMed     Text format     Abstract available

    Br J Cancer

  7. P SANTOS I, van Doorn R, Caspers PJ, Bakker Schut TC, et al
    Improving clinical diagnosis of early-stage cutaneous melanoma based on Raman spectroscopy.
    Br J Cancer. 2018 Nov 9. pii: 10.1038/s41416-018-0257.
    PubMed     Text format     Abstract available

    Cancer Lett

  8. CHIU CS, Tsai CH, Hsieh MS, Tsai SC, et al
    Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and beta-catenin pathways.
    Cancer Lett. 2018 Oct 31. pii: S0304-3835(18)30640.
    PubMed     Text format     Abstract available

    Cancer Res

  9. ARNST KE, Wang Y, Hwang DJ, Xue Y, et al
    A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance.
    Cancer Res. 2018;78:265-277.
    PubMed     Text format     Abstract available

  10. CANALE FP, Ramello MC, Nunez N, Araujo Furlan CL, et al
    CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8(+) T Cells.
    Cancer Res. 2018;78:115-128.
    PubMed     Text format     Abstract available

    Clin Cancer Res

  11. LIM SY, Lee JH, Gide TN, Menzies AM, et al
    Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-PD-1-based immunotherapy.
    Clin Cancer Res. 2018 Nov 8. pii: 1078-0432.CCR-18-2795.
    PubMed     Text format     Abstract available

    Eur J Dermatol

  12. MINOWA T, Kato J, Hida T, Horimoto K, et al
    Prognostic role of platelet to lymphocyte and lymphocyte to monocyte ratios in advanced melanoma treated with anti-programmed death-1.
    Eur J Dermatol. 2018 Nov 8. pii: ejd.2018.3381. doi: 10.1684/ejd.2018.3381.
    PubMed     Text format    

    Int J Cancer

  13. POTJER TP, Bollen S, Grimbergen AJEM, van Doorn R, et al
    Multi-gene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families.
    Int J Cancer. 2018 Nov 10. doi: 10.1002/ijc.31984.
    PubMed     Text format     Abstract available

    J Am Acad Dermatol

  14. BERTOLLI E, Petaccia de Macedo M, Calsavara VF, Lopes Pinto CA, et al
    A nomogram to identify high-risk melanoma patients with a negative sentinel node biopsy.
    J Am Acad Dermatol. 2018 Nov 2. pii: S0190-9622(18)32831.
    PubMed     Text format     Abstract available

  15. GHAZAWI FM, Le M, Alghazawi N, Rahme E, et al
    Trends in Incidence of Cutaneous Malignant Melanoma in Canada: 1992-2010 versus 2011-2015.
    J Am Acad Dermatol. 2018 Nov 2. pii: S0190-9622(18)32826.
    PubMed     Text format    

  16. KELM RC, Hagstrom EL, Mathieu RJ, Orrell KA, et al
    Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) Program.
    J Am Acad Dermatol. 2018 Nov 2. pii: S0190-9622(18)32823.
    PubMed     Text format    

  17. SWETTER SM, Tsao H, Bichakjian CK, Curiel-Lewandrowski C, et al
    Guidelines of care for the management of primary cutaneous melanoma.
    J Am Acad Dermatol. 2018 Oct 29. pii: S0190-9622(18)32588.
    PubMed     Text format     Abstract available

    J Clin Oncol

  18. KLUGER HM, Chiang V, Mahajan A, Zito CR, et al
    Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial.
    J Clin Oncol. 2018 Nov 8:JCO1800204. doi: 10.1200/JCO.18.00204.
    PubMed     Text format     Abstract available

    J Invest Dermatol

  19. AMSCHLER K, Beyazpinar I, Erpenbeck L, Kruss S, et al
    Morphological Plasticity of Human Melanoma Cells is Determined by Nanoscopic Patterns of E- and N-Cadherin Interactions.
    J Invest Dermatol. 2018 Oct 27. pii: S0022-202X(18)32710.
    PubMed     Text format     Abstract available

    Melanoma Res

  20. YANG N, Lu J, Lu Y, Guo J, et al
    Primary malignant melanotic melanoma and hypomelanotic melanoma of the female urethra: case series and a review of the literature in China.
    Melanoma Res. 2018 Nov 2. doi: 10.1097/CMR.0000000000000521.
    PubMed     Text format     Abstract available

  21. SALMI S, Siiskonen H, Sironen R, Tyynela-Korhonen K, et al
    The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
    Melanoma Res. 2018 Nov 5. doi: 10.1097/CMR.0000000000000522.
    PubMed     Text format     Abstract available

    Nat Med

  22. ROBERT C
    Is earlier better for melanoma checkpoint blockade?
    Nat Med. 2018;24:1645-1648.
    PubMed     Text format     Abstract available

    PLoS One

  23. SEYED JAFARI SM, Wiedmer C, Cazzaniga S, Frangez Z, et al
    Correlation of Vascular Endothelial Growth Factor subtypes and their receptors with melanoma progression: A next-generation Tissue Microarray (ngTMA) automated analysis.
    PLoS One. 2018;13:e0207019.
    PubMed     Text format     Abstract available

  24. SVEDMAN FC, Lohcharoenkal W, Bottai M, Brage SE, et al
    Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma.
    PLoS One. 2018;13:e0206942.
    PubMed     Text format     Abstract available

  25. POTEZ M, Trappetti V, Bouchet A, Fernandez-Palomo C, et al
    Characterization of a B16-F10 melanoma model locally implanted into the ear pinnae of C57BL/6 mice.
    PLoS One. 2018;13:e0206693.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.